Clinical Research Directory
Browse clinical research sites, groups, and studies.
Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol
Sponsor: Hillel Yaffe Medical Center
Summary
Ovarian endometriomas are cystic masses lined with endometrial tissue that contains fluid arising from a collection of menstrual debris. Ovarian endometriomas clinical manifestations includes pelvic pain, dysmenorrhea, dysfunctional uterine bleeding, and infertility. Endometriomas are most commonly treated either medically or by surgical excision. Ultrasonography (US)-guided aspiration and sclerotherapy is a new approach. Its mechanism of action is believed to be destruction of the inner epithelial lining, which is followed by inflammation and fibrosis, eventually resulting in regression of the cyst. The main advantage in this approach is the avoidance of collateral damage to the ovary.
Official title: Endometrioma Ethanol Sclerotherapy and Its Effect on Ovarian Function and Fertility Treatment Outcome - Prospective Cohort Study Protocol
Key Details
Gender
FEMALE
Age Range
18 Years - 41 Years
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2022-08-09
Completion Date
2027-12-31
Last Updated
2025-05-14
Healthy Volunteers
No
Conditions
Interventions
Sclerotherapy
ultrasound (US)-guided sclerotherapy for the treatment of ovarian endometrioma
Locations (1)
Hillel Yaffe Medical Center
Hadera, Israel